| Quarter (USD) | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 63.77 mm | 63.77 mm | 63.77 mm | 63.77 mm | 63.77 mm | 63.77 mm |
| Cash burn (monthly) | 3.37 mm | (no burn) | 4.41 mm | 3.88 mm | 3.28 mm | 2.83 mm |
| Cash used (since last report) | 141.12 mm | n/a | 184.55 mm | 162.38 mm | 136.98 mm | 118.41 mm |
| Cash remaining | -77.34 mm | n/a | -120.77 mm | -98.61 mm | -73.20 mm | -54.63 mm |
| Runway (months of cash) | -22.9 | n/a | -27.4 | -25.4 | -22.3 | -19.3 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 49 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 9.24 mm |
| Total shares | 3.80 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| HealthCap VI | 3.80 mm | $9.24 mm |
| Orbimed Advisors | 0.00 | $0.00 |
| Caxton | 0.00 | $0.00 |
